Zobrazeno 1 - 10
of 4 659
pro vyhledávání: '"Immunotherapy, Active"'
Autor:
Vernet R; Centre for Translational Research in Onco-Hematology, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland., Fernandez E; Department of Oncology, Geneva University Hospitals and Medical School, Geneva, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland., Migliorini D; Department of Oncology, Geneva University Hospitals and Medical School, Geneva, Switzerland.; Centre for Translational Research in Onco-Hematology, University of Geneva, Geneva, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland., Ancrenaz V; Department of Oncology, Geneva University Hospitals and Medical School, Geneva, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland., Charrier E; Centre for Translational Research in Onco-Hematology, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland.; MaxiVAX SA, Geneva, Switzerland., Belkouch MC; Centre for Translational Research in Onco-Hematology, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland., Von Rohr O; Centre for Translational Research in Onco-Hematology, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland., Urwyler M; Centre for Translational Research in Onco-Hematology, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland., De Vito C; Division of Clinical Pathology, Diagnostic Department, Geneva University Hospitals, Geneva, Switzerland., Renaux J; MaxiVAX SA, Geneva, Switzerland., Villard J; Clinical Cell Therapy Lab, Geneva University Hospital, Geneva, Switzerland., Rubin O; Clinical Cell Therapy Lab, Geneva University Hospital, Geneva, Switzerland., Grogg J; MaxiVAX SA, Geneva, Switzerland., Mach N; Department of Oncology, Geneva University Hospitals and Medical School, Geneva, Switzerland.; Centre for Translational Research in Onco-Hematology, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 Aug 01; Vol. 4 (8), pp. 2089-2100.
Autor:
Kovacech B; Axon Neuroscience R&D Services SE, Dvorakovo Nabr. 10, 81102, Bratislava, Slovakia. kovacech@axon-neuroscience.eu., Cullen NC; Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Clinical Research Centre, Jan Waldenströms Gata 35, 202 13, Malmö, Sweden., Novak P; Axon Neuroscience R&D Services SE, Dvorakovo Nabr. 10, 81102, Bratislava, Slovakia., Hanes J; Axon Neuroscience R&D Services SE, Dvorakovo Nabr. 10, 81102, Bratislava, Slovakia., Kontsekova E; Axon Neuroscience R&D Services SE, Dvorakovo Nabr. 10, 81102 Bratislava, Slovakia and Institute of Neuroimmunology, Slovak Academy of Sciences, Dubravska Cesta 9, Bratislava, 84510, Slovakia., Katina S; Department of Mathematics and Statistics, Axon Neuroscience R&D Services SE, Bratislava, Slovakia, and (current) Masaryk University, Kotlářská 267/2, Brno, 611 37, Czech Republic., Parrak V; Axon Neuroscience R&D Services SE, Dvorakovo Nabr. 10, 81102, Bratislava, Slovakia., Fresser M; Axon Neuroscience SE, 4 Arch. Makariou & Kalogreon, 6016, Larnaca, Cyprus., Vanbrabant J; ADx NeuroSciences NV, Technologiepark 6, 9052, Ghent, Belgium., Feldman HH; Department of Neurosciences, Alzheimer's Disease Cooperative Study, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA., Winblad B; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, BioClinicum, 171 64, Solna, Sweden.; Theme Inflammation and Aging, Karolinska University Hospital, 141 86, Stockholm, Sweden., Stoops E; ADx NeuroSciences NV, Technologiepark 6, 9052, Ghent, Belgium., Vanmechelen E; ADx NeuroSciences NV, Technologiepark 6, 9052, Ghent, Belgium., Zilka N; Axon Neuroscience R&D Services SE, Dvorakovo Nabr. 10, 81102, Bratislava, Slovakia. zilka@axon-neuroscience.eu.
Publikováno v:
Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Nov 23; Vol. 16 (1), pp. 254. Date of Electronic Publication: 2024 Nov 23.
Immunotherapeutic approaches for Alzheimer's disease: Exploring active and passive vaccine progress.
Autor:
Bhadane P; School of Pharmacy & Technology Management, SVKM's NMIMS University, Mukesh Patel Technology Park, Shirpur 425405, India., Roul K; School of Pharmacy & Technology Management, SVKM's NMIMS University, Mukesh Patel Technology Park, Shirpur 425405, India., Belemkar S; Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS Deemed to be University, Vile Parle (W) Mumbai 400 056, India., Kumar D; School of Pharmacy & Technology Management, SVKM's NMIMS University, Mukesh Patel Technology Park, Shirpur 425405, India. Electronic address: devendrak.phe@gmail.com.
Publikováno v:
Brain research [Brain Res] 2024 Oct 01; Vol. 1840, pp. 149018. Date of Electronic Publication: 2024 May 21.
Autor:
Eijsvogel P; Centre for Human Drug Research and Leiden University Medical Centre, Leiden, The Netherlands., Misra P; Department of Neurology, Mayo Clinic, Rochester, MN, USA., Concha-Marambio L; R&D Unit, Amprion Inc, San Diego, CA, USA., Boyd JD; Vaxxinity Inc, Merritt Island, FL, USA., Ding S; Vaxxinity Inc, Merritt Island, FL, USA., Fedor L; Vaxxinity Inc, Merritt Island, FL, USA., Hsieh YT; Vaxxinity Inc, Merritt Island, FL, USA., Sun YS; Vaxxinity Inc, Merritt Island, FL, USA., Vroom MM; Vaxxinity Inc, Merritt Island, FL, USA., Farris CM; R&D Unit, Amprion Inc, San Diego, CA, USA., Ma Y; R&D Unit, Amprion Inc, San Diego, CA, USA., de Kam ML; Centre for Human Drug Research Leiden, Leiden, The Netherlands., Radanovic I; Centre for Human Drug Research and Leiden University Medical Centre, Leiden, The Netherlands., Vissers MFJM; Centre for Human Drug Research and Leiden University Medical Centre, Leiden, The Netherlands., Mirski D; Vaxxinity Inc, Merritt Island, FL, USA., Shareghi G; Mitchell Center for Alzheimer's Disease and Related Brain Disorders, University of Texas McGovern Medical School, Houston, TX, USA., Shahnawaz M; Mitchell Center for Alzheimer's Disease and Related Brain Disorders, University of Texas McGovern Medical School, Houston, TX, USA., Singer W; Department of Neurology, Mayo Clinic, Rochester, MN, USA., Kremer P; Centre for Human Drug Research and Leiden University Medical Centre, Leiden, The Netherlands., Groeneveld GJ; Centre for Human Drug Research and Leiden University Medical Centre, Leiden, The Netherlands., Yu HJ; Vaxxinity Inc, Merritt Island, FL, USA., Dodart JC; Vaxxinity Inc, Merritt Island, FL, USA. jc@vaxxinity.com.
Publikováno v:
Nature medicine [Nat Med] 2024 Sep; Vol. 30 (9), pp. 2631-2640. Date of Electronic Publication: 2024 Jun 20.
Autor:
Mora J; Bristol Myers Squibb, Lawrenceville, NJ, USA., Palmer R; Sanofi, Cambridge, MA, USA., Wagner L; US FDA, Silver Spring, MD, USA., Wu B; Janssen R&D, Spring House, PA, USA., Partridge M; Regeneron, Tarrytown, NY, USA., Meena; Stoke, Cambridge, MA, USA., Sonderegger I; Takeda, Opfikon, Switzerland., Smeraglia J; AstraZeneca, Cambridge, UK., Bivi N; Eli Lilly & Company, Indianapolis, IN, USA., Dakappagari N; Navigate, a Novartis Subsidiary, San Diego, CA, USA., Diebold S; UK MHRA, London, UK., Garofolo F; BRI Frontage, Vancouver, BC, Canada., Grimaldi C; Regeneron, Tarrytown, NY, USA., Kalina W; Pfizer, Groton, CT, USA., Kamerud J; Pfizer, Groton, CT, USA., Kar S; WRIB, Toronto, ON, Canada., Marshall JC; Moderna, Mystic, CT, USA., Mayer C; Austria AGES, Vienna, Austria., Melton A; BioMarin, Novato, CA, USA., Merdek K; Bristol Myers Squibb, Lawrenceville, NJ, USA., Nolan K; Merck, West Point, PA, USA., Picard S; Bristol Myers Squibb, Lawrenceville, NJ, USA., Shao W; AstraZeneca, Cambridge, UK., Seitzer J; Intellia, Cambridge, MA, USA., Tanaka Y; Japan MHLW, Tokyo, Japan., Tounekti O; Health Canada, Ottawa, ON, Canada., Vigil A; Boehringer Ingelheim, Danbury, CT, USA., Walravens K; GlaxoSmithKline, Rixensart, Belgium., Xu J; US FDA, Jefferson, AR, USA.; Regenxbio, Rockville, MD, USA., Xu W; Merck, West Point, PA, USA., Xu Y; Intellia, Cambridge, MA, USA., Yang L; US FDA, Jefferson, AR, USA.; Regenxbio, Rockville, MD, USA., Zhu L; Moderna, Mystic, CT, USA., Verthelyi D; US FDA, Silver Spring, MD, USA., Kubiak RJ; AstraZeneca, Gaithersburg, MD, USA., Coble K; Boehringer Ingelheim, Danbury, CT, USA., Gupta S; AbbVie, Irvine, CA, USA., Abhari MR; US FDA, Silver Spring, MD, USA., Richards S; Sanofi, Cambridge, MA, USA., Song Y; Genentech, South San Francisco, CA, USA., Ullmann M; Fresenius Kabi, Bad Homburg, Germany., Calderon B; Eli Lilly & Company, Indianapolis, IN, USA., Cludts I; UK MHRA, London, UK., Gunn GR; GlaxoSmithKline, Collegeville, PA, USA., Gupta S; Amgen, Thousand Oaks, CA, USA., Ishii-Watabe A; Japan MHLW, Tokyo, Japan., Manangeeswaran M; US FDA, Silver Spring, MD, USA., Maxfield K; US FDA, Silver Spring, MD, USA., McCush F; Pfizer, Groton, CT, USA., O'Day C; Seattle Genetics, Bothell, WA, USA., Peng K; Genentech, South San Francisco, CA, USA., Poetzl J; Sandoz, Oberhaching, Germany., Rasamoelisolo M; Sandoz, Oberhaching, Germany., Saad OM; Genentech, South San Francisco, CA, USA., Scheibner K; US FDA, Silver Spring, MD, USA., Shubow S; US FDA, Silver Spring, MD, USA., Song S; Takeda, Cambridge, MA, USA., Thacker S; US FDA, Silver Spring, MD, USA.
Publikováno v:
Bioanalysis [Bioanalysis] 2024 Apr; Vol. 16 (7), pp. 77-119. Date of Electronic Publication: 2024 Feb 22.
Autor:
Cao C; State Key Laboratory of Oral Diseases, West China Hospital of Stomatology/Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, P.R. China., Gan X; State Key Laboratory of Oral Diseases, West China Hospital of Stomatology/Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, P.R. China., Hu X; Department of Nursing, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, P.R. China., Su Y; Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, P.R. China., Zhang Y; Affiliated Hospital of Chengdu University, Chengdu 610041, Sichuan, P.R. China., Peng X; Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, P.R. China.
Publikováno v:
Aging [Aging (Albany NY)] 2022 Mar 10; Vol. 14 (5), pp. 2062-2080. Date of Electronic Publication: 2022 Mar 10.
Autor:
Cullen NC; Department of Clinical Sciences, Lund University, Lund, Sweden., Novak P; Axon Neuroscience CRM Services, Bratislava, Slovakia. Electronic address: petr.novak@axon-neuroscience.eu., Tosun D; San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA; Department of Radiology and Biomedical Imaging, University of California San Francisco, CA, USA., Kovacech B; Axon Neuroscience R&D Services, Bratislava, Slovakia., Hanes J; Axon Neuroscience R&D Services, Bratislava, Slovakia., Kontsekova E; Axon Neuroscience R&D Services, Bratislava, Slovakia., Fresser M; Axon Neuroscience SE, Larnaca, Cyprus., Ropele S; Clinical Division of General Neurology, Department of Neurology, Medical University Graz, Graz, Austria., Feldman HH; Department of Neurosciences, Alzheimer's Disease Cooperative Study, University of California San Diego, La Jolla, CA, USA., Schmidt R; Clinical Division of Neurogeriatrics, Department of Neurology, Medical University Graz, Graz, Austria., Winblad B; Karolinska Institutet, Department of NVS, Division of Neurogeriatrics, Solna, Sweden and Karolinska University Hospital, Theme Inflammation and Aging, Huddinge, Sweden., Zilka N; Axon Neuroscience R&D Services, Bratislava, Slovakia.
Publikováno v:
EBioMedicine [EBioMedicine] 2024 Jan; Vol. 99, pp. 104923. Date of Electronic Publication: 2023 Dec 14.
Autor:
Fleming SM; Department of Pharmaceutical Sciences, Northeast Ohio Medical University, USA. Electronic address: sfleming1@neomed.edu., Davis A; Department of Pharmaceutical Sciences, Northeast Ohio Medical University, USA., Simons E; Department of Pharmaceutical Sciences, Northeast Ohio Medical University, USA.
Publikováno v:
Neuropharmacology [Neuropharmacology] 2022 Jan 01; Vol. 202, pp. 108870. Date of Electronic Publication: 2021 Nov 03.
Autor:
Takei J; Department of Neurosurgery, The Jikei University School of Medicine, 3-25-8 Nishishinbashi, Minato-Ku, Tokyo, 105-8461, Japan.; Division of Oncology, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, Japan., Kamata Y; Division of Oncology, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, Japan., Tanaka T; Department of Neurosurgery, The Jikei University School of Medicine, 3-25-8 Nishishinbashi, Minato-Ku, Tokyo, 105-8461, Japan.; Department of Neurosurgery, The Jikei University Kashiwa Hospital, Chiba, Japan., Fukasawa N; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Gomisawa K; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Satake M; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Mori R; Department of Neurosurgery, The Jikei University School of Medicine, 3-25-8 Nishishinbashi, Minato-Ku, Tokyo, 105-8461, Japan., Yamamoto Y; Department of Neurosurgery, The Jikei University Daisan Hospital, Tokyo, Japan., Suzuki T; Department of Neurosurgery, The Jikei University School of Medicine, 3-25-8 Nishishinbashi, Minato-Ku, Tokyo, 105-8461, Japan., Oda A; Department of Neurosurgery, The Jikei University School of Medicine, 3-25-8 Nishishinbashi, Minato-Ku, Tokyo, 105-8461, Japan., Murahashi M; Division of Oncology, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, Japan., Fukuda T; Medical Center for Memory and Cognitive Disorders, Sasebo Chuo Hospital, Nagasaki, Japan., Shimoda M; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Murayama Y; Department of Neurosurgery, The Jikei University School of Medicine, 3-25-8 Nishishinbashi, Minato-Ku, Tokyo, 105-8461, Japan., Akasaki Y; Department of Neurosurgery, The Jikei University School of Medicine, 3-25-8 Nishishinbashi, Minato-Ku, Tokyo, 105-8461, Japan. akasaki@jikei.ac.jp.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Oct; Vol. 72 (10), pp. 3175-3189. Date of Electronic Publication: 2023 Jun 29.
Autor:
Ye Y; NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China., Tian H; NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China., Jiang J; NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China., Huang W; NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China., Zhang R; NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China., Li H; NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China., Liu L; NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China., Gao J; NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China., Tan H; NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China., Liu M; NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China., Peng F; School of Materials Science and Engineering, Sun Yat-Sen University, Guangzhou, 510275, China., Tu Y; NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China.
Publikováno v:
Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2023 Sep; Vol. 10 (25), pp. e2300540. Date of Electronic Publication: 2023 Jun 29.